Individuals Coming Off Anti-Obesity Jabs Gain Back Pounds Four Times Faster Compared to Those on Conventional Diets

Fresh analysis reveals that individuals who stop using popular GLP-1 drugs like Mounjaro or Wegovy tend to recover reduced body mass far faster than those who stop traditional lifestyle programs.

Published data in a major medical journal shows that while obese individuals can lose substantial amounts of their total mass while undergoing treatment, the weight is regained at an estimated rate of 0.8 kg per month after stopping.

"Users purchasing these drugs need to be cognizant of the danger of quick weight regain when the therapy ends," warns researcher Dr. Susan Jebb.

Such speed of regain implies a reversion to pre-treatment weight within about one and a half years.

Analyzing Approaches

The study, which looked at dozens of studies involving thousands of patients, compared the outcomes of the injectable medications with older methods.

Researchers note that people who lose weight through lifestyle changes alone usually have a less rapid weight regain—approximately 0.1 kg a month—post-intervention.

Explaining the Quick Rebound

Doctors propose the mode of action of the drugs accounts for the heightened weight return.

These medications mimic a body's own chemical called glucagon-like peptide-1, which helps regulate hunger.

"Artificially providing GLP-1 concentrations several times higher than normal may cause the system to produce less of its endogenous GLP-1, and may also reduce responsiveness to its effects," noted Dr. Adam Collins, a dietetics specialist.

"Withdrawal of this medication leads to appetite is unsuppressed, making binge eating far more likely."

A Chronic Disease?

Medical guidelines recommend the injections for people with weight-linked health risks, alongside recommended lifestyle changes.

Professionals argue that, given the likelihood of relapse, the treatment might need to be life-long.

This perspective is reinforced by drug manufacturers, who say that the findings "highlight the long-term character of obesity," similar to managing conditions like hypertension.

User Experiences

Users who have come off the medication explain a intense return of cravings.

"I experienced a switch flipping and I was suddenly starving," said one woman.

This challenge is worsened if individuals have not developed lasting lifestyle or habit modifications during therapy.

Significant Interest

Figures indicate that millions of people in the UK have used weight-loss jabs in the past year, with demand being substantial.

• Adoption is greater among females than males.
• The 40s and 50s demographic shows the highest usage rates.
• A large proportion access the drugs through private prescriptions rather than public health services.

Ultimately, researchers stress that while these medications are powerful agents for shedding pounds, they are not a permanent fix and lasting health benefits relies on ongoing lifestyle management.